IP Library Granted Patent US 12,517,109
Granted Patent B2
US 12,517,109 · App. 18/534,014 · Granted Jan 6, 2026

Sample-testing system for measuring properties of red blood cells

Inventors: Ung Hyeon Ko (Seoul, KR); Eun Young Park (Seoul, KR); Seung Jin Kang (Seoul, KR)
Assignee: ORANGE BIOMED LTD., CO.
G01N33/4915A61B5/02A61B5/026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,517,109
App. No.
18/534,014
Granted
Jan 6, 2026
Kind
B2
Abstract

The present disclosure relates to systems, devices and methods for measuring analyte levels. A glycated hemoglobin level measuring system includes a sample-testing cartridge having a microchannel that passively transfers and compresses cells. The system can perform one or more calibration or normalization routines on sensor data to generate calibrated or normalized data. The calibrated or normalized data can be used to determine one or more analyte levels.

Claims (23)

1 . A method for analyzing red blood cells in a patient blood sample, the method comprising:

transferring, via capillary action, red blood cells through a microchannel sized to compress the red blood cells, wherein the microchannel includes (i) a first region having a first cross-sectional dimension and (ii) a second region downstream of the first region and having a second cross-sectional dimension less than the first cross-sectional dimension;

analyzing, using one or more sensor circuits positioned along the microchannel, movement of individual ones of the red blood cells moving along the microchannel;

determining a plurality of ratios based on the analyzed movement of the individual ones of the red blood cells, wherein each of the ratios is between a first speed of a respective one of the red blood cells at the first region of the microchannel and a second speed of the respective one of the red blood cells at the second region of the microchannel, and wherein the second speed is different from the first speed; and

determining an analyte characteristic of the red blood cells based on the determined plurality of ratios.

2 . The method of claim 1 , wherein the analyzing the movement of individual ones of the red blood cells comprises obtaining a voltage signal, wherein the first speed corresponds to a width of a peak of the voltage signal, and wherein the second speed corresponds to a width of a trough of the voltage signal.

3 . The method of claim 1 , wherein the determining the analytic characteristic comprises determining one or more degrees of symmetry of shapes of the red blood cells.

4 . The method of claim 1 , further comprising:

determining a distribution of the determined ratios for the red blood cells, wherein determining the analyte characteristic of the red blood cells is further determined based on the distribution.

5 . The method of claim 1 , wherein the transferring the red blood cells comprises evaporating the red blood cells via an outlet of the microchannel.

6 . The method of claim 1 , wherein determining the analyte characteristic comprises determining a glycated hemoglobin level of the red blood cells based on the determined ratios.

7 . The method of claim 1 , wherein determining the analyte characteristic comprises determining an HbA1c percentage of the red blood cells based on the determined ratios.

8 . The method of claim 1 , wherein determining the analyte characteristic comprises determining a blood disease associated with the red blood cells based on the determined ratios.

9 . The method of claim 1 , further comprising:

measuring the first speed using a first set of sensors at the first region of the microchannel; and

measuring the second speed using a second set of sensors at the second region of the microchannel, wherein the second region is spaced apart from the first region.

10 . The method of claim 9 , wherein determining the analyte characteristic comprises determining a glycated hemoglobin level of the red blood cells, and wherein the glycated hemoglobin level is inversely correlated with the determined ratios.

11 . The method of claim 1 , wherein:

determining the plurality of ratios comprises removing or at least partially canceling out one or more variability factors such that each of the determined ratios primarily represents a rigidity of the respective one of the red blood cells, and

determining the analyte characteristic comprises:

determining a distribution of the determined ratios for the red blood cells;

comparing the determined distribution to a plurality of distribution graphs, wherein each distribution graph (i) corresponds to a unique value of the analyte characteristic and (ii) plots a plurality of ratios corresponding to a plurality of red blood cells; and

identifying one of the plurality of distribution graphs that substantially matches the determined distribution.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2025
From: KO, UNG HYEON; PARK, EUN YOUNG; KANG, SEUNG JIN
To: ORANGE BIOMED LTD., CO.
Reel/Frame 073851/0981 →
CHANGE OF NAME Recorded Sep 13, 2024
From: ORANGE BIOMED LTD., CO.
To: ORANGE BIOMED CO., LTD.
Reel/Frame 069198/0843 →
Continuity (2)
Provisional Application 63386887 · Dec 9, 2022
Related Publication 20240192193A1 · Jun 13, 2024
References Cited (100)
US 5206144A · Zeuthen et al. · 1993 [cited by applicant]
US 5642734A · Ruben et al. · 1997 [cited by applicant]
US 6204668B1 · Sequeira et al. · 2001 [cited by applicant]
US 6399293B1 · Pachl et al. · 2002 [cited by applicant]
US 6949070B2 · Ishler · 2005 [cited by applicant]
US 8252163B2 · Sugiyama et al. · 2012 [cited by applicant]
US 8759095B2 · Vink · 2014 [cited by applicant]
US 8789405B2 · Sugiyama · 2014 [cited by applicant]
US 9017536B2 · Oishi et al. · 2015 [cited by applicant]
US 9080939B2 · Tsai et al. · 2015 [cited by applicant]
US 9429579B2 · Sugiyama et al. · 2016 [cited by applicant]
US 9795328B2 · Taub et al. · 2017 [cited by applicant]
US 9977037B2 · Yoshida et al. · 2018 [cited by applicant]
US 10641724B2 · Ainger et al. · 2020 [cited by applicant]
US 10996187B2 · Lee et al. · 2021 [cited by applicant]
US 11009479B2 · Liu et al. · 2021 [cited by applicant]
US 11111517B2 · Ichiyanagi et al. · 2021 [cited by applicant]
US 11376590B2 · Gurkan et al. · 2022 [cited by applicant]
US 11385244B2 · Shigemitsu et al. · 2022 [cited by applicant]
US 11400452B2 · Jagtiani · 2022 [cited by applicant]
US 11747348B2 · Ko · 2023 [cited by applicant]
US 11852577B2 · Ko · 2023 [cited by applicant]
US 12019082B2 · Ko · 2024 [cited by applicant]
US 12025548B2 · Ko · 2024 [cited by applicant]
US 20050014249A1 · Staimer · 2005 [cited by applicant]
US 20060184037A1 · Ince · 2006 [cited by applicant]
US 20060244964A1 · Cox · 2006 [cited by applicant]
US 20070195127A1 · Ahn · 2007 [cited by examiner]
US 20070267361A1 · Tyvoll · 2007 [cited by applicant]
US 20100089774A1 · Manohar et al. · 2010 [cited by applicant]
US 20100145174A1 · Alferness et al. · 2010 [cited by applicant]
US 20100178660A1 · Adamczyk et al. · 2010 [cited by applicant]
US 20120148805A1 · Goad · 2012 [cited by applicant]
US 20150268244A1 · Cho et al. · 2015 [cited by applicant]
US 20170227495A1 · Gurkan · 2017 [cited by applicant]
US 20180235524A1 · Dunn et al. · 2018 [cited by applicant]
US 20180364186A1 · Watkins et al. · 2018 [cited by applicant]
US 20190107533A1 · Nagi · 2019 [cited by applicant]
US 20190232287A1 · Depa et al. · 2019 [cited by applicant]
US 20200101456A1 · Watkins et al. · 2020 [cited by applicant]
US 20200200734A1 · Yu et al. · 2020 [cited by applicant]
US 20210025904A1 · Snodgrass et al. · 2021 [cited by applicant]
US 20210072137A1 · Michel et al. · 2021 [cited by applicant]
US 20210229102A1 · Jagtiani · 2021 [cited by applicant]
US 20210239717A1 · Clarke et al. · 2021 [cited by applicant]
US 20210293693A1 · Bharadwaj et al. · 2021 [cited by applicant]
US 20220065876A1 · Connolly · 2022 [cited by applicant]
US 20220097080A1 · Weber · 2022 [cited by applicant]
US 20220120768A1 · Nishiyama · 2022 [cited by applicant]
US 20220134339A1 · Hayashino et al. · 2022 [cited by applicant]
US 20220176378A1 · Jagtiani · 2022 [cited by applicant]
US 20220187184A1 · Al et al. · 2022 [cited by applicant]
US 20220362779A1 · Jagtiani · 2022 [cited by applicant]
EP 1162449A1 · 2001 [cited by applicant]
EP 2047909A2 · 2009 [cited by applicant]
EP 2182345B1 · 2013 [cited by applicant]
EP 2568281B1 · 2018 [cited by applicant]
EP 2144057B1 · 2019 [cited by applicant]
EP 2995947B1 · 2020 [cited by applicant]
JP 2002538459A · 2002 [cited by applicant]
JP H08292193A · 2003 [cited by applicant]
JP 2012529033A · 2012 [cited by applicant]
JP 2017521679A · 2017 [cited by applicant]
KR 20030008223A · 2003 [cited by examiner]
KR 20050120637A · 2005 [cited by applicant]
KR 20070061042A · 2007 [cited by applicant]
KR 20120111878A · 2012 [cited by applicant]
KR 20130066841A · 2013 [cited by applicant]
KR 20150108050A · 2015 [cited by examiner]
KR 20150126476A · 2015 [cited by applicant]
KR 101584083B1 · 2016 [cited by applicant]
KR 101666847B1 · 2016 [cited by applicant]
KR 20160014142A · 2016 [cited by applicant]
KR 101681170B1 · 2016 [cited by applicant]
KR 101802289B1 · 2017 [cited by applicant]
KR 101818368B1 · 2018 [cited by applicant]
KR 101884314B1 · 2018 [cited by applicant]
KR 101885964B1 · 2018 [cited by applicant]
KR 101995253B1 · 2019 [cited by applicant]
KR 1020200006695A · 2020 [cited by applicant]
KR 102104654B1 · 2020 [cited by applicant]
KR 20200097068A · 2020 [cited by applicant]
KR 102174557B1 · 2020 [cited by applicant]
KR 102281500B1 · 2021 [cited by applicant]
KR 102315843B1 · 2021 [cited by applicant]
KR 102403577B1 · 2022 [cited by applicant]
KR 102439240B1 · 2022 [cited by applicant]
KR 102439474B1 · 2022 [cited by examiner]
WO 2010137470A1 · 2010 [cited by applicant]
WO 2013153406A1 · 2013 [cited by applicant]
Ko, KR102439474B1 “Method and device for determining HbA1c levels using mechanical and electrical characteristics of RBCs” Google Translation (Year: 2024). [cited by examiner]
Han et al., KR20150108050A “Apparatus for measuring cell deformability” Google Translation (Year: 2024). [cited by examiner]
Hardeman et al., Laser-Assisted Optical Rotational Cell Analyser (L.O.R.C.A.); I. A New Instrument for Measurement of Various Structural Hemorheological Parameters, Clinical Hemorheology, vol. 14, No. 4, pp. 605-618, 19… [cited by examiner]
Shin, S. KR20030008223A “Vacuum Viscometer” Google Translation (Year: 2024). [cited by examiner]
International Search Report and Written Opinion mailed Mar. 17, 2023 for PCT Application No. PCT/KR2022/019905; 6 pages. [cited by applicant]
International Search Report mailed on Jul. 11, 2022 for International Patent Application No. PCT/KR2021/018280, 3 pages. [cited by applicant]
Tsai , et al., “Impedance measurement system for automatic determination of glycated hemoglobin”, Rev. Sci. Instrum. 89, 065003, https://doi.org/10.1063/1.5025151, Jun. 28, 2018, 10 pages. [cited by applicant]
Makris, Konstantinos, and Loukia Spanou, “Is there a relationship between mean blood gluclose and glycated hemoglobin?” Journal of diabetes science and technology 5.6 (2011); 1572-1583. (Year 2011). [cited by applicant]
International Search Report and Written Opinion issued by Korean Intellectual Property Office for PCT/IB2023/062425 on Mar. 22, 2024, 10 pages. [cited by applicant]
Wu, Tenghu, and James J. Feng. “Simulation of malaria-infected red blood cells in microfluidic channels: Passage and blockage.” Biomicrofluidics 7.4 (2013). (Year: 2013). [cited by applicant]